A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Roman, Pablo ^a,b   Estévez, Angeles F ^a   Miras, Alonso ^c   Sánchez Labraca, Nuria ^a   Cañadas, Fernando ^a   Vivas, Ana B ^d   Cardona, Diana ^a  

^a UNIVERSITY OF ALMERÍA   (Spain)

^b UNIVERSITAT JAUME I   (Spain)

^c Independent Researcher   (Spain)

^d UNIVERSITY OF SHEFFIELD   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

COGNITION; CONTROLLED STUDY; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; FEMALE; FIBROMYALGIA; HUMAN; IMPULSIVENESS; INTESTINE FLORA; MALE; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

COGNITION; DECISION MAKING; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; FIBROMYALGIA; GASTROINTESTINAL MICROBIOME; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; QUALITY OF LIFE;

EID: 85050625431     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-29388-5     Document Type: Article

References (68)

1. Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G. & Cryan, J. F. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv. Exp. Med. Biol. 817, 373–403 (2014).
2. Dinan, T. G., Borre, Y. E. & Cryan, J. F. Genomics of schizophrenia: time to consider the gut microbiome? Mol. Psychiatry 19, 1252–7 (2014).
3. Cryan, J. F. & Dinan, T. G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701–12 (2012).
4. Carabotti, M., Scirocco, A., Maselli, M. A. & Severi, C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 28, 203–209 (2015).
5. Bercik, P. & Collins, S. M. The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Adv. Exp. Med. Biol. 817, 279–89 (2014).
6. De Palma, G., Collins, S. M., Bercik, P. & Verdu, E. F. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J. Physiol. 592, 2989–97 (2014).
7. Sherwin, E., Rea, K., Dinan, T. G. & Cryan, J. F. A gut (microbiome) feeling about the brain. Curr. Opin. Gastroenterol. 32, 96–102 (2016).
8. Mayer, E. E. A. et al. Gut/brain axis and the microbiota. 125 (2015).
9. Dinan, T. G. & Quigley, E. M. Probiotics in the treatment of depression: science or science fiction? Aust. N. Z. J. Psychiatry 45, 1023–5 (2011).
10. Kaur, I. P., Chopra, K. & Saini, A. Probiotics: potential pharmaceutical applications. Eur. J. Pharm. Sci. 15, 1–9 (2002).
11. Dinan, T. G., Stanton, C. & Cryan, J. F. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720–6 (2013).
12. Diaz Heijtz, R. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 108, 3047–52 (2011).
13. Huang, R., Wang, K. & Hu, J. Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 8, 483 (2016).
14. Benton, D., Williams, C. & Brown, A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 61, 355–61 (2007).
15. Messaoudi, M. et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105, 755–64 (2011).
16. Messaoudi, M. et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2, 256–61 (2011).
17. Pinto-Sanchez, M. I. et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology 153, 448–459.e8 (2017).
18. Logan, A. C. & Katzman, M. Major depressive disorder: probiotics may be an adjuvant therapy. Med. Hypotheses 64, 533–8 (2005).
19. Wolfe, F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33, 160–72 (1990).
20. Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken). 62, 600–10 (2010).
21. Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 38, 1113–22 (2011).
22. Geisser, M. E. et al. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102, 243–50 (2003).
23. Montoya, P., Larbig, W., Braun, C., Preissl, H. & Birbaumer, N. Influence of social support and emotional context on pain processing and magnetic brain responses in fibromyalgia. Arthritis Rheum. 50, 4035–44 (2004).
24. Montoya, P. et al. Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom. Med. 67, 957–63 (2005).
25. Staud, R. et al. Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 105, 215–22 (2003).
26. Glass, J. M. Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum. Dis. Clin. North Am. 35, 299–311 (2009).
27. Glass, J. M. Fibromyalgia and cognition. 69 Suppl 2, 20–4 (2008).
28. Glass, J. M. et al. Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia. J. Pain 12, 1219–29 (2011).
29. Glass, J. M. & Park, D. C. Cognitive dysfunction in fibromyalgia. Curr. Rheumatol. Rep. 3, 123–7 (2001).
30. Glass, J. M. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Curr. Rheumatol. Rep. 8, 425–9 (2006).
31. Glass, J. M., Park, D. C., Minear, M. & Crofford, L. J. Memory beliefs and function in fibromyalgia patients. J. Psychosom. Res. 58, 263–9 (2005).
32. Gelonch, O., Garolera, M., Rosselló, L. & Pifarré, J. [Cognitive dysfunction in fibromyalgia]. Rev. Neurol. 56, 573–88 (2013).
33. Correa, A., Miró, E., Martínez, M. P., Sánchez, A. I. & Lupiáñez, J. Temporal preparation and inhibitory deficit in fibromyalgia syndrome. Brain Cogn. 75, 211–6 (2011).
34. Leavitt, F. & Katz, R. S. Distraction as a key determinant of impaired memory in patients with fibromyalgia. J. Rheumatol. 33, 127–32 (2006).
35. Verdejo-García, A., López-Torrecillas, F., Calandre, E. P., Delgado-Rodríguez, A. & Bechara, A. Executive function and decision-making in women with fibromyalgia. Arch. Clin. Neuropsychol. 24, 113–22 (2009).
36. Walteros, C. et al. Altered associative learning and emotional decision making in fibromyalgia. J. Psychosom. Res. 70, 294–301 (2011).
37. Holmes, R. D., Tiwari, A. K. & Kennedy, J. L. Mechanisms of the placebo effect in pain and psychiatric disorders. Pharmacogenomics J, 10.1038/tpj.2016.15 (2016).
38. Chen, X. et al. The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials. Clin. Rheumatol, 10.1007/s10067-017-3595-8 (2017).
39. Tillisch, K. The effects of gut microbiota on CNS function in humans. Gut Microbes 5, 404–10 (2014).
40. Kantak, P. A., Bobrow, D. N. & Nyby, J. G. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav. Pharmacol. 25, 71–9 (2014).
41. Collins, S. M. & Bercik, P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136, 2003–14 (2009).
42. Wall, R. et al. Bacterial Neuroactive Compounds Produced by Psychobiotics. Adv. Exp. Med. Biol. 817, 221–239 (2014).
43. Özogul, F. Effects of specific lactic acid bacteria species on biogenic amine production by foodborne pathogen. Int. J. Food Sci. Technol. 46, 478–484 (2011).
44. Dalley, J. W., Everitt, B. J. & Robbins, T. W. Impulsivity, Compulsivity, and Top-Down Cognitive Control. Neuron 69, 680–694 (2011).
45. Winstanley, C. A., Eagle, D. M. & Robbins, T. W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev. 26 (2006).
46. Klein, A. B. et al. 5-HT2A and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains. Neuroscience 263, 36–45 (2014).
47. Moreno, M. et al. Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences. Neuropsychopharmacology 35, 1198–208 (2010).
48. Koning, C. J. M. et al. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am. J. Gastroenterol. 103, 178–89 (2008).
49. Lee, S., Malhotra, B., Creanga, D., Carlsson, M. & Glue, P. A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder. BMC Med. Res. Methodol. 9, 55 (2009).
50. Roman, P. et al. Probiotics for Fibromyalgia: Study design for a pilot double-blind, randomized controlled trial. Nutr. Hosp. 34, 1285–1290 (2017).
51. Huskisson, E. C. Measurement of pain, 10.1016/S0140-6736(74)90884-8 (1974).
52. Carlsson, A. M. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16, 87–101 (1983).
53. Burckhardt, C. S., Clark, S. R. & Bennett, R. M. The fibromyalgia impact questionnaire: development and validation. J. Rheumatol. 18, 728–33 (1991).
54. Monterde, S., Salvat, I., Montull, S. & Fernández-Ballart, J. Validación de la versión española del Fibromyalgia Impact Questionnaire. Rev. Española Reumatol. 31, 507–513 (2004).
55. Esteve-Vives, J., Rivera Redondo, J., Isabel Salvat Salvat, M., de Gracia Blanco, M. & de Miquel, C. A. Proposal for a consensus version of the Fibromyalgia Impact Questionnaire (FIQ) for the Spanish population. Reumatol. Clin. 3, 21–4 (2007).
56. Ware, J. E. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–83 (1992).
57. Alonso, J., Prieto, L. & Antó, J. M. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med. clínica 104, 771–6 (1995).
58. Spielberger, C. D., Gorsuch, R. L. & Lushene, R. E. Manual for the State-Trait Anxiety Inventory. (1970).
59. Seisdedos, N. Cuestionario de Ansiedad Estado-Rasgo [STAI]. (TEA, 1982).
60. Beck, A. T. et al. An Inventory for Measuring Depression. Arch. Gen. Psychiatry 4, 561 (1961).
61. Conde, V. & Useros, E. Adaptación castellana de la escala de evaluación conductual para la depresión de Beck. Rev Psiquiat Psicol Med Eur Am Lat 217–236 (1975).
62. Bonilla, J., Bernal, G., Santos, A. & Santos, D. A revised Spanish version of the Beck Depression Inventory: psychometric properties with a Puerto Rican sample of college students. J. Clin. Psychol. 60, 119–30 (2004).
63. Lasa, L., Ayuso-Mateos, J. L., Vázquez-Barquero, J. L., Díez-Manrique, F. J. & Dowrick, C. F. The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. J. Affect. Disord. 57, 261–5 (2000).
64. Lobo, A., Escobar, V., Ezquerra, J. & Seva Díaz, A. ‘El Mini-Examen Cognoscitivo’(Un test sencillo, práctico, para detectar alteraciones intelectuales en pacientes psiquiátricos). Rev. Psiquiatr. y Psicol. Médica 14, 39–57 (1980).
65. Cherek, D. R. & Lane, S. D. Laboratory and psychometric measurements of impulsivity among violent and nonviolent female parolees. Biol. Psychiatry 46, 273–80 (1999).
66. Bechara, A., Damasio, A. R., Damasio, H. & Anderson, S. W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50, 7–15 (1994).
67. Cohen, J. Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Statistical Power Analysis for the Behavioral Sciences 2nd (1988).
68. Cohen, J. A power primer. Psychol. Bull. 112, 155–159 (1992).